SINGULAIR MSD 117 (Singulair 10 mg)
Generic Name: montelukast
Pill imprint SINGULAIR MSD 117 has been identified as Singulair 10 mg.
Singulair is used in the treatment of allergic rhinitis; asthma, maintenance; bronchospasm prophylaxis; asthma and belongs to the drug class leukotriene modifiers. There is no proven risk in humans during pregnancy. Singulair 10 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- montelukast
- Imprint:
- SINGULAIR MSD 117
- Strength:
- 10 mg
- Color:
- Brown
- Shape:
- Four-sided
- Availability:
- Prescription only
- Drug Class:
- Leukotriene modifiers
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Merck & Company Inc
- National Drug Code (NDC):
- 00006-9117
- Inactive Ingredients:
- microcrystalline cellulose
lactose monohydrate
croscarmellose sodium
hydroxypropyl cellulose (type h)
magnesium stearate
hypromelloses
titanium dioxide
ferric oxide red
ferric oxide yellow
carnauba wax
More about Singulair (montelukast)
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
